NCT06065748 · Interventional trial
A Study to Evaluate Efficacy and Safety of Giredestrant Compared With Fulvestrant (Plus a CDK4/6 Inhibitor), in Participants With ER-Positive, HER2-Negative Advanced Breast Cancer Resistant to Adjuvant Endocrine Therapy (pionERA Breast Cancer)
Overall registry status Active not recruiting
Phase 3
Conditions Estrogen Receptor-Positive, HER2-Negative Advanced Breast Cancer
Delaware Valley sites
- Abramson Cancer Center; Univ of Pennsylvania; Clinical Research Unit · Philadelphia, PA · Philadelphia County
- Alliance Cancer Specialists · Bensalem, PA · Bucks County
First posted
Registry updated
Added to the directory